Abstract:The immune (innate and adaptive) system has evolved to protect the host from any danger present in the surrounding outer environment (microbes and associated MAMPs or PAMPs, xenobiotics, and allergens) and dangers originated within the host called danger or damage-associated molecular patterns (DAMPs) and recognizing and clearing the cells dying due to apoptosis. It also helps to lower the tissue damage during trauma and initiates the healing process. The pattern recognition receptors (PRRs) play a crucial role in recognizing different PAMPs or MAMPs and DAMPs to initiate the pro-inflammatory immune response to clear them. Toll-like receptors (TLRs) are first recognized PRRs and their discovery proved milestone in the field of immunology as it filled the gap between the first recognition of the pathogen by the immune system and the initiation of the appropriate immune response required to clear the infection by innate immune cells (macrophages, neutrophils, dendritic cells or DCs, and mast cells). However, in addition to their expression by innate immune cells and controlling their function, TLRs are also expressed by adaptive immune cells. We have identified 10 TLRs (TLR1-TLR10) in humans and 12 TLRs (TLR1-TLR13) in laboratory mice till date as TLR10 in mice is present only as a defective pseudogene. The present chapter starts with the introduction of innate immunity, timing of TLR evolution, and the evolution of adaptive immune system and its receptors (T cell receptors or TCRs and B cell receptors or BCRs). The next section describes the role of TLRs in the innate immune function and signaling involved in the generation of inflammation. The subsequent sections describe the expression and function of different TLRs in murine and human adaptive immune cells (B cells and different types of T cells, including CD4+T cells, CD8+T cells, CD4+CD25+Tregs, and CD8+CD25+Tregs, etc.). The modulation of TLRs expressed on T and B cells has a great potential to develop different vaccine candidates, adjuvants, immunotherapies to target various microbial infections, including current COVID-19 pandemic, cancers, and autoimmune and autoinflammatory diseases.

Toll样受体在角膜免疫中的研究进展

Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation

Toll-like Receptor 3 and Tumor Immunity

Innate Recognition and Immune Regulation of NK Cells in Immune-Related Diseases

��巢癌患者cd4^＋cd25^＋调节性t细胞比例增高的可能机制

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Study for complementarity determining region 3 of T cell receptor beta chain in infectious diseases

Pattern recognition by Toll-like receptors

Progress on B Cell Activation Mediated by Toll-Like Receptor 9

Toll-like receptor control of the adaptive immune responses

Toll-like receptors in inflammation, infection and cancer

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals

Toll-like Receptors and The Innate Immunity and Adaptive Immunity Mediated by Dendritic Cells

Toll-like receptors: critical proteins linking innate and acquired immunity

Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response

Recognition and Interaction of Innate Immune Receptors

Brucella infection and Toll-like receptors

Toll-Like Receptors in Adaptive Immunity

Selectivity of Toll-like receptor stimulation in human B cells (HUM8P.350)

Toll-like receptors and their relations with ocular surface diseases